Infection
582
37
49
340
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
65 trials with published results (11%)
Research Maturity
340 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.5%
38 terminated out of 582 trials
89.9%
+3.4% vs benchmark
18%
107 trials in Phase 3/4
19%
65 of 340 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 340 completed trials
Clinical Trials (582)
Tattooing and Piercing Among Medical Students
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
Cross-sectional Characterization of Idiopathic Bronchiectasis
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
Surgical Recovery Support Pillow for Spine Surgeries
Prediction and Prevention of Bloodstream Infections After Kidney Transplantation
Metagenomics for Ocular Inflammation
DRONE-WOUND Study: Severe Infection After Drone-Related Combat Trauma
Persona Revision Knee System Outcomes
Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children
Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection
Naproxen Versus Placebo as Adjunct Treatment of Cellulitis
Metagenomic Next-Generation Sequencing for the Diagnosis of Fracture-related Infection
Molecular Microbiology- Guided Antimicrobial Stewardship Versus Standard Stewardship in Hospitalized Patients
The Extended Study of Prevalence of Infection in Intensive Care IV
Impact of Genotyping P450 2C19 on Hospitalization Period
Diagnosis and Management of Inflammatory and Infectious Diseases
PancRea: Risk Factors and Outcomes of Infected Pancreatic Necrosis
Comparison of Peripheral Perfusion Level Between Two Groups of Newborns According to Their Infectious Status Defined by the Criteria of the Center for Disease Control and Prevention (CDC)
Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests